As of 4:02pm ET
| -1.00 / -1.01%|
The 14 analysts offering 12-month price forecasts for Charles River Laboratories International Inc have a median target of 103.00, with a high estimate of 121.00 and a low estimate of 73.00. The median estimate represents a +4.63% increase from the last price of 98.44.
The current consensus among 19 polled investment analysts is to Buy stock in Charles River Laboratories International Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.